DeepMed Research

NATIONAL INSTITUTE ON DRUG ABUSE AND ADDICTION

🇵🇰Pakistan

Country: 🇵🇰Pakistan

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)

Phase 1

Not yet recruiting

Conditions: Healthy Volunteers

First Posted Date: 2025-03-11

Last Posted Date: 2025-05-21

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 35

Registration Number: NCT06868914

Locations: 🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States

Environment and Alcohol: A Pilot Study

Phase 1

Recruiting

Conditions: Alcohol Use Disorder

First Posted Date: 2025-03-06

Last Posted Date: 2025-05-21

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 44

Registration Number: NCT06860607

Locations: 🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States

VK4-116 Phase I Study with Food-Effect

Phase 1

Not yet recruiting

Conditions: Opioid Dependence
Opioid Use Disorder (OUD)

Interventions: Drug: VK4-116

First Posted Date: 2025-02-05

Last Posted Date: 2025-02-05

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 48

Registration Number: NCT06808932

Locations: 🇺🇸
Altasciences Clinical Kansas, Overland Park, Kansas, United States

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

Recruiting

Conditions: Alcoholism
Substance-Related Disorders

First Posted Date: 2024-11-06

Last Posted Date: 2025-05-21

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 10000

Registration Number: NCT06676059

Locations: 🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States

Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder

Not Applicable

Not yet recruiting

Conditions: Healthy Volunteers
Opioid Use Disorder

Interventions: Device: TMS (MagVenture MagPro 100 with MagOption)

First Posted Date: 2024-08-29

Last Posted Date: 2025-05-21

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 60

Registration Number: NCT06577454

Locations: 🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States

Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making

Early Phase 1

Recruiting

Conditions: Normal Physiology

Interventions: Device: continuous Theta Burst Stimulation (cTBS)
Device: intermittent Theta Burst Stimulation (iTBS)
Device: sham Theta Burst Stimulation (sham TBS)

First Posted Date: 2024-08-20

Last Posted Date: 2025-05-21

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 600

Registration Number: NCT06561828

Locations: 🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States

Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP

Recruiting

Conditions: Alcohol Use Disorder
Substance Use Disorder

First Posted Date: 2024-08-14

Last Posted Date: 2025-04-29

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 10000

Registration Number: NCT06552741

Locations: 🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States

Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study

Not Applicable

Recruiting

Conditions: Healthy Volunteers
Vaping Teens

Interventions: Behavioral: Mindfulness-based Stress Reduction (MBSR) Program

First Posted Date: 2024-07-16

Last Posted Date: 2025-05-15

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 120

Registration Number: NCT06503159

Locations: 🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States

SXC-2023 Cocaine Interaction Study

Phase 1

Completed

Conditions: Cocaine Use Disorder

Interventions: Drug: SXC-2023 Placebo
Drug: SXC-2023

First Posted Date: 2024-04-02

Last Posted Date: 2025-05-20

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 17

Registration Number: NCT06343532

Locations: 🇺🇸
Altasciences Clinical Kansas, Inc., Overland Park, Kansas, United States

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

Phase 3

Recruiting

Conditions: Methamphetamine Abuse
Methamphetamine-dependence

Interventions: Drug: extended-release naltrexone (XR-NTX)
Drug: iPLB
Drug: extended release bupropion (BUP-XL) tablets (BUP-XL)
Drug: oPLB

First Posted Date: 2024-01-31

Last Posted Date: 2024-12-10

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 360

Registration Number: NCT06233799

Locations: 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸
University of California Los Angeles, Los Angeles, California, United States
🇺🇸
University of California at San Diego, San Diego, California, United States

and more 7 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy